Every material Form 8-K DaVita filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
DaVita Inc. announced consolidated revenues of $3.578 billion and diluted earnings per share of $3.40 for the third quarter ended September 30, 2026. The company also updated its full-year 2026 guidance ranges for adjusted operating income and adjusted diluted earnings per share.
Consolidated revenues for Q3 2026 were $3.578 billion with an operating income of $499 million.
Diluted earnings per share was $3.40 and adjusted diluted earnings per share was $3.82 for the quarter ended September 30, 2026.
The company repurchased 0.6 million shares for $111 million during the third quarter of 2026 at an average price of $186.21 per share.
Updated 2026 guidance projects adjusted operating income between $2.175 billion and $2.250 billion.
DaVita reported results for the quarter ended June 30, 2026, with total revenues of $3.554 billion, up from $3.380 billion a year earlier, and diluted earnings per share of $4.02, up from $2.58. Operating income rose to $579 million from $538 million, and the company reaffirmed its 2026 guidance ranges for adjusted operating income, adjusted diluted EPS, and free cash flow. The results show gains in revenue, operating income, and per-share profit for shareholders.
Total revenues were $3.554 billion, compared with $3.380 billion in the second quarter of 2025.
Diluted EPS was $4.02, compared with $2.58 a year earlier; operating income was $579 million, a 16.3% margin.
Current 2026 guidance: adjusted operating income of $2,150 million to $2,250 million and adjusted diluted EPS of $14.10 to $15.20.
During the quarter the company repurchased 2.2 million shares for $348 million and added a $500 million Term Loan B-2 tranche.
DaVita entered a Ninth Amendment to its credit agreement on June 8, 2026, providing a $500 million incremental term loan due May 2031. The company says it has used or will use the proceeds to repay part of its senior secured revolving loan, pay fees and expenses, and for general corporate purposes. At its June 4, 2026 annual meeting, stockholders elected all nine director nominees, ratified KPMG LLP as auditor, and approved executive compensation on an advisory basis.
$500 million incremental Tranche B-2 term loan, maturing May 2031, denominated in U.S. dollars
Interest at Term SOFR plus 175 basis points, or Base Rate plus 75 basis points, at the company's option
Proceeds to repay part of the senior secured revolving loan maturing November 2030, plus fees and general corporate purposes
Annual meeting on June 4, 2026: nine directors elected, KPMG LLP ratified, and say-on-pay approved; about 91% of shares represented
DaVita reported first-quarter 2026 revenue of $3.416 billion, up from $3.224 billion a year earlier, and operating income of $482 million, up from $439 million. It also raised its 2026 adjusted diluted EPS guidance to $14.10 to $15.20 from $13.60 to $15.00, which matters to shareholders because it signals higher expected profit for the year. Compared with the fourth quarter of 2025, revenue and operating income were lower.
Q1 2026 diluted EPS from continuing operations was $2.87, versus $2.00 in Q1 2025 and $2.94 in Q4 2025.
2026 adjusted operating income guidance rose to $2,150 million to $2,250 million from $2,085 million to $2,235 million.
Free cash flow guidance for 2026 was unchanged at $1,000 million to $1,250 million.
The company repurchased 3.0 million shares for $403 million in Q1 2026 and 2.0 million more shares for $302 million from April 1 through May 5, 2026.
DaVita reported fourth-quarter 2025 revenue of $3.620 billion, up from $3.295 billion a year earlier, while GAAP diluted EPS from continuing operations fell to $2.94 from $3.09 and operating income was $561 million versus $565 million. The company also issued 2026 guidance of $13.60 to $15.00 adjusted diluted EPS, $2.085 billion to $2.235 billion adjusted operating income, and $1.000 billion to $1.250 billion free cash flow, compared with 2025 adjusted diluted EPS of $10.78.
Q4 2025 consolidated revenue was $3.620 billion versus $3.295 billion in Q4 2024; operating income was $561 million versus $565 million.
Q4 2025 diluted EPS from continuing operations was $2.94 (Q4 2024: $3.09); adjusted diluted EPS was $3.40 (Q3 2025: $2.51).
2026 guidance: adjusted operating income of $2,085 million to $2,235 million and adjusted diluted EPS of $13.60 to $15.00.
Repurchased 2.7 million shares for $331 million in Q4 2025, and 1.7 million shares for $200 million from January 1 through February 2, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every DaVita filing is on SEC EDGAR ↗. 8-K briefs of other companies →